1. Embelin induces apoptosis of human gastric carcinoma through inhibition of p38 MAPK and NF-κB signaling pathways
   CHANG-LONG XU et al, 2016 CrossRef
2. Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factor-κB, monocyte chemoattractant protein-1, activator protein-1 and restoration of heat shock protein 72
   XUEFENG LIN et al, 2015 CrossRef
3. Widdrol, a sesquiterpene isolated from Juniperus chinensis, inhibits angiogenesis by targeting vascular endothelial growth factor receptor 2 signaling.
   Soojung Jin et al, 2015, Oncol Rep CrossRef
4. Deguelin induces PUMA-mediated apoptosis and promotes sensitivity of lung cancer cells (LCCs) to doxorubicin (Dox)
   Aimei Wang et al, 2017, Mol Cell Biochem CrossRef
5. Deguelin, a Novel Anti-Tumorigenic Agent in Human Esophageal Squamous Cell Carcinoma
   Yuh Baba et al, 2017, EBioMedicine CrossRef
6. null
   Sankar Jagadeeshan et al, 2018 CrossRef
7. Deguelins, Natural Product Modulators of NF1-Defective Astrocytoma Cell Growth Identified by High-Throughput Screening of Partially Purified Natural Product Extracts
   Curtis J. Henrich et al, 2015, J. Nat. Prod. CrossRef
8. Deguelin inhibits proliferation and migration of human pancreatic cancer cells in vitro targeting hedgehog pathway
   Wen Zheng et al, 2016 CrossRef
9. Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin
   Xiao Xu et al, 2017, IJMS CrossRef
10. Concise Total Synthesis of (±)-Deguelin and (±)-Tephrosin Using a Vinyl Iodide as a Key Building Block
    Shengtao Xu et al, 2018, J. Nat. Prod. CrossRef
11. Gefitinib inhibits retina angiogenesis by affecting VEGF signaling pathway
    Haitao Hu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
12. Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten -Null Cells
    Adam Naguib et al, 2018, Cell Reports CrossRef
13. null
    Bee Ling Tan et al, 2018 CrossRef
14. Updated review of potential medicinal genetic resources in the USDA, ARS, PGRCU industrial and legume crop germplasm collections
    J. Bradley Morris et al, 2018, Industrial Crops and Products CrossRef
15. The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts
    Masatoshi Nukui et al, 2018, Viruses CrossRef
16. Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on “The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts”
    Beatrice Mercorelli et al, 2019, Viruses CrossRef
17. Molecular interaction studies of Deguelin and its derivatives with Cyclin D1 and Cyclin E in cancer cell signaling pathway: The computational approach
    Kiran Bharat Lokhande et al, 2019, Sci Rep CrossRef
18. Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential.
    Rahel Sarah Varughese et al, 2019, Cancer CrossRef
19. Myrothecine A modulates the proliferation of HCC cells and the maturation of dendritic cells through downregulating miR-221
    Yi Fu et al, 2019, International Immunopharmacology CrossRef
20. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
    Lin Li et al, 0 CrossRef
21. Chrysin-organogermanium (IV) complex induced Colo205 cell apoptosis-associated mitochondrial function and anti-angiogenesis
    Fen Yang et al, 2015 CrossRef
22. Modulation of signal transduction pathways by natural compounds in cancer
    Alok Ranjan et al, 2015, Chinese Journal of Natural Medicines CrossRef
23. BAD, a Proapoptotic Protein, Escapes ERK/RSK Phosphorylation in Deguelin and siRNA-Treated HeLa Cells
    Samra Hafeez et al, 2016, PLoS ONE CrossRef
24. Deguelin-induced blockade of PI3K/protein kinase B/MAP kinase signaling in zebrafish and breast cancer cell lines is mediated by down-regulation of fibroblast growth factor receptor 4 activity
    Wei Wu et al, 2016, Pharmacol Res Perspect CrossRef
25. Inhibitory effect of trans-ferulic acid on proliferation and migration of human lung cancer cells accompanied with increased endogenous reactive oxygen species and β-catenin instability
    Yao Fong et al, 2016, Chin Med CrossRef
26. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects.
    Si-Min Tang et al, 2020, Biomed Pharmacother CrossRef
27. Deguelin inhibits HCV replication through suppressing cellular autophagy via down regulation of Beclin1 expression in human hepatoma cells
    Weibo Liao et al, 2020, Antiviral Research CrossRef
28. Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy
    Sanya Haiaty et al, 2020, IUBMB Life CrossRef
29. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.
    Mehmet A Kocdor et al, 2019, Anticancer Agents Med Chem CrossRef
30. Anticancer Activity of Natural Flavonoids: Inhibition of HIF-1α Signaling Pathway
    Xiangping Deng et al, 2020, COC CrossRef
31. null
    Mehmet Varol, 2020 CrossRef
32. Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathway
    Ming Li et al, 2018, Oncotarget CrossRef
33. Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis
    Wei Li et al, 2017, Oncotarget CrossRef
34. Molecules that target nucleophosmin for cancer treatment: an update
    Adele Di Matteo et al, 2016, Oncotarget CrossRef
35. Deguelin exerts anticancer activity of human gastric cancer MGC-803 and MKN-45 cells in vitro
    Wen Kang et al, 2018, Int J Mol Med CrossRef
36. Berbamine induces SMMC-7721 cell apoptosis via upregulating p53, downregulating survivin expression and activating mitochondria signaling pathway
    Ying Cao et al, 2017, Exp Ther Med CrossRef
37. Nucleophosmin in Its Interaction with Ligands
    Ilaria Cela et al, 2020, IJMS CrossRef
38. An Electrophilic Deguelin Analogue Inhibits STAT3 Signaling in H-Ras-Transformed Human Mammary Epithelial Cells: The Cysteine 259 Residue as a Potential Target
    Sung-Jun Hong et al, 2020, Biomedicines CrossRef
39. Deguelin targets multiple oncogenic signaling pathways to combat human malignancies
    Hardeep Singh Tuli et al, 2021, Pharmacological Research CrossRef
40. Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds
    Abedul Haque et al, 2021, European Journal of Cancer CrossRef
41. Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway
    Guowei Gong et al, 2021, J. Nat. Prod. CrossRef
42. Olive polyphenols attenuate TNF-α-stimulated M-CSF and IL-6 synthesis in osteoblasts: Suppression of Akt and p44/p42 MAP kinase signaling pathways
    Tomoyuki Hioki et al, 2021, Biomedicine & Pharmacotherapy CrossRef
43. Pharmacological basis and new insights of deguelin concerning its anticancer effects
    Zhu Yue Lin et al, 2021, Pharmacological Research CrossRef
44. null
    Benito Soto-Blanco, 2022 CrossRef
45. Natural Products and Their Derivatives against Human Herpesvirus Infection
    Chattarin Ruchawapol et al, 2021, Molecules CrossRef
46. Chemical inducer of regucalcin attenuates lipopolysaccharide‐induced inflammatory responses in pancreatic MIN6 β‐cells and RAW264.7 macrophages
    Tomiyasu Murata et al, 2021, FEBS Open Bio CrossRef
47. Dynamic contrast-enhanced MRI perfusion parameters are imaging biomarkers for angiogenesis in lung cancer
    Yonghao Du et al, 2022, Acta Radiol CrossRef
48. Therapeutic Potential of Natural Products in the Treatment of Renal Cell Carcinoma: A Review
    Chenchen Feng et al, 2022, Nutrients CrossRef
49. Recent Advances in Chemotherapeutic Implications of Deguelin: A Plant- Derived Retinoid
    Manzoor A. Mir et al, 2021, NPJ CrossRef
50. Overview of the multifaceted resistances toward EGFR-TKIs and new chemotherapeutic strategies in non-small cell lung cancer
    Rashidi Dzul Keflee et al, 2022, Biochemical Pharmacology CrossRef
51. Identification of allosteric inhibitor against AKT1 through structure-based virtual screening
    Keerthana Karunakaran et al, 2022, Mol Divers CrossRef
52. The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment
    Chenicheri Kizhakkeveettil Keerthana et al, 2023, Front. Immunol. CrossRef
53. Ginsenoside Rg5 attenuates hypoxia‐induced cardiomyocyte apoptosis via regulating the Akt pathway
    Chenxi Wang et al, 2023, Chem Biol Drug Des CrossRef
54. Docking and simulation studies on cyclin D/CDK4 complex for targeting cell cycle arrest in cancer using flavanone and its congener
    Sagar Nagare et al, 2023, J Mol Model CrossRef
55. The Natural Flavonoid Compound Deguelin Suppresses Sperm (Sus Scrofa) Functions through Abnormal Activation of the PI3K/AKT Pathway
    Woo-Jin Lee et al, 2023, Reproductive Toxicology CrossRef
56. From the ethnomedicinal plants in northern Indochina to the development of novel anti-cancer therapeutic agents
    Mattapong Kulaphisit et al, 2023, Med Chem Res CrossRef
57. Inhibitory Effects of B-, C-, and E-Ring-Truncated Deguelin Derivatives Against A549, HCT116, and MCF-7 Cancer Cells
    John Alfon P. Francisco et al, 2023, ACS Omega CrossRef
58. Resveratrol inhibits basic fibroblast growth factor-induced macrophage colony-stimulating factor synthesis via the PI3-kinase/Akt pathway in osteoblasts
    Gen Kuroyanagi et al, 2023 CrossRef
59. Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway
    Kening Sun et al, 2024 CrossRef